Ovintiv (NYSE:OVV – Get Free Report) had its price target boosted by The Goldman Sachs Group from $47.00 to $56.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price target would suggest a potential upside of 8.97% from the company’s […]